Cargando…

Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease

Lysophosphatidic acid (LPA) is an endogenous lysophospholipid and a bioactive lipid that is synthesized by the enzyme autotaxin (ATX). The ATX–LPA axis has been associated with cognitive dysfunction and inflammatory diseases, mainly in a range of nonalcoholic liver diseases. Recently, preclinical an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flores-López, María, García-Marchena, Nuria, Pavon, Francisco Javier, Lara, Estrella, Porras-Perales, Oscar, Araos, Pedro, Requena-Ocaña, Nerea, Torres-Galván, Sandra, Mañas-Padilla, M. Carmen, Rubio, Gabriel, Suárez, Juan, Santín, Luis J., Rodríguez de Fonseca, Fernando, Castilla-Ortega, Estela, García-Fernández, María I., Serrano, Antonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469650/ https://www.ncbi.nlm.nih.gov/pubmed/34572393 http://dx.doi.org/10.3390/biomedicines9091207

Ejemplares similares

Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
por: García-Marchena, Nuria, et al.
Publicado: (2020)

Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2023)

Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
por: Flores-López, María, et al.
Publicado: (2022)

Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
por: Flores-López, María, et al.
Publicado: (2023)

Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
por: Araos, Pedro, et al.
Publicado: (2019)

Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder
por: Galván, Sandra Torres, et al.
Publicado: (2021)

Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders
por: García-Marchena, Nuria, et al.
Publicado: (2017)

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
por: She, Sha, et al.
Publicado: (2022)

Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex
por: García-Marchena, Nuria, et al.
Publicado: (2022)

Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
por: Ramesh, Sindhu, et al.
Publicado: (2018)

Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
por: Valdés-Rives, Silvia Anahi, et al.
Publicado: (2017)

Linking medicinal cannabis to autotaxin–lysophosphatidic acid signaling
por: Eymery, Mathias C, et al.
Publicado: (2023)

Expression of proteins related to autotaxin–lysophosphatidate signaling in thyroid tumors
por: Shin, Eunah, et al.
Publicado: (2019)

MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis
por: Murph, Mandi M.
Publicado: (2019)

Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity
por: Pedraz, María, et al.
Publicado: (2015)

Influence of gender and education on cocaine users in an outpatient cohort in Spain
por: Requena-Ocaña, Nerea, et al.
Publicado: (2021)

Sex Differences in Psychiatric Comorbidity and Plasma Biomarkers for Cocaine Addiction in Abstinent Cocaine-Addicted Subjects in Outpatient Settings
por: Pedraz, María, et al.
Publicado: (2015)

Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling
por: Keune, Willem-Jan, et al.
Publicado: (2016)

Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer
por: Yun, C. Chris
Publicado: (2019)

Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders
por: Alioli, Candide, et al.
Publicado: (2022)

Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders
por: García-Marchena, Nuria, et al.
Publicado: (2018)

Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2021)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
por: Herrera-Imbroda, Jesús, et al.
Publicado: (2023)

Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
por: Herrera-Imbroda, Jesús, et al.
Publicado: (2023)

L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin
por: Clair, Timothy, et al.
Publicado: (2005)

Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo
por: Benesch, Matthew G.K., et al.
Publicado: (2016)

Expression of Autotaxin–Lysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma
por: Cha, Yoon Jin, et al.
Publicado: (2019)

Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2022)

Influence of the autotaxin-lysophosphatidic acid axis on cellular function and cytokine expression in different breast cancer cell lines
por: Hauck, Theresa, et al.
Publicado: (2022)

1-Oleoyl Lysophosphatidic Acid: A New Mediator of Emotional Behavior in Rats
por: Castilla-Ortega, Estela, et al.
Publicado: (2014)

The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
por: Tabuchi, Sadaharu
Publicado: (2015)

Autotaxin-Lysophosphatidic Acid Axis Is a Novel Molecular Target for Lowering Intraocular Pressure
por: Iyer, Padma, et al.
Publicado: (2012)

Autotaxin/lysophosphatidic acid signaling mediates obesity‐related cardiomyopathy in mice and human subjects
por: Weng, Jiakan, et al.
Publicado: (2018)

The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer
por: Erstad, Derek J., et al.
Publicado: (2017)

KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers
por: Wang, Shuo, et al.
Publicado: (2022)

Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
por: Requena-Ocaña, Nerea, et al.
Publicado: (2023)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer
por: Brindley, David N., et al.
Publicado: (2020)

Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
por: Zulfikar, Sabrina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fd3rljm8cu9nu2orm6gp474s7s